Disclosures Management of Rejection - UCSF CME€¦ · Management of Rejection Connie Frank...
Transcript of Disclosures Management of Rejection - UCSF CME€¦ · Management of Rejection Connie Frank...
9/30/2016
1
Connie Frank Transplant Center
Deborah B Adey, MDProfessor of Medicine
University of California, San FranciscoKidney and Pancreas Transplant Center
Management of Rejection
Connie Frank Transplant Center
Disclosures I have no disclosures (relevant or otherwise)
Connie Frank Transplant Center
Objectives • Recognize there are different types of
rejection of a kidney transplant • Describe the inherent differences
between cellular and antibody mediated rejection
• Understand the expected outcomes based on the type and severity of acute rejection
Connie Frank Transplant Center
Rejection: DefinitionA directed cellular or humoral response of the recipient against the foreign tissue (allograft) from the donor
9/30/2016
2
Connie Frank Transplant Center
Question #1Rejection is always a concern of the transplant recipient, the primary care provider, and the transplant care team.
Connie Frank Transplant Center
Question #1 Which of the following statements is NOT true about rejection after transplant:1. The risk of rejection is always high, every bump
in creatinine is probably rejection – these patients are like time bombs.
2. There are different types of rejection and treatment is based on the type of rejection
3. Outcomes after treatment of rejection depend on the timing and severity of the rejection
4. Most patients will have a rejection episode after transplant
Connie Frank Transplant Center
Question #1 Which of the following statements is NOT true about rejection after transplant:1. The risk of rejection is always high, every
bump in creatinine is a probably rejection –these patients are like time bombs.
2. There are different types of rejection and treatment is based on the type of rejection
3. Outcomes after treatment of rejection depend on the timing and severity of the rejection
4. Most patients will have a rejection episode after transplant
Connie Frank Transplant Center
Types of Rejection• Cellular • Antibody Medicated • Mixed Cellular and Antibody Mediated
9/30/2016
3
Connie Frank Transplant Center
Timing of Rejection
• Immediate: First 2-6 weeks after transplant.• Early: First 6 weeks to 12 months after
transplant.• Late: > 12 Months to years after transplant.
Connie Frank Transplant Center USRDS 2012 ADR
Acute rejection within the first year post-transplantFigure 7.19 (Volume 2)
Patients age 18 & older with a functioning graft at discharge.
Connie Frank Transplant Center
ACUTE REJECTION
• Pathogenesis• Cell-mediated.
– Chiefly T-cells but others may be involved.• Clinical
– Rise in serum creatinine of 20%-25% over baseline creatinine
– Rarely do patients have fever, pain over the allograft, hematuria, flu-like symptoms
Connie Frank Transplant Center
Banff classification • Antibody-mediated rejection
• Acute• C4d+• C4d-
• Chronic • C4d+• C4d-
• Borderline changes• T-cell-mediated rejection
• Acute (1A, 1B, 2A, 2B, 3) • Chronic active
• Interstitial fibrosis and tubular atrophy• No evidence of any specific etiology
• Other
9/30/2016
4
Connie Frank Transplant Center
Question #2 A 42 yo woman is s/p living donor transplant 10 weeks ago for kidney disease related to polycystic kidney disease and is seen for routine follow-up at 3 months. Her baseline creatinine is 1.2 mg/dl and has been stable for the past 5 weeks. She did have a flu like syndrome 2 weeks ago when other members of her household were also ill, but feels well now. Her creatinine is noted to be 1.8 mg/dl from yesterday. An ultrasound is done to rule out obstruction and is normal, and her labs repeated with a creatinine of 1.9 mg/dl. Her immunosuppression drug level is within target range and she denies problems with missing any doses of medications.Arrangements are made to do a biopsy tomorrow.
Connie Frank Transplant Center
Question #2The most likely diagnosis and outcome are:1. Chronic rejection and she will lose the
allograft2. Acute rejection and this will probably be
treatable with a decent outcome 3. Recurrent disease and the kidney is not
going to work4. Acute rejection and the kidney is not
going to recover
Connie Frank Transplant Center
Question #2The most likely diagnosis and outcome are:1. Chronic rejection and she will lose the
allograft2. Acute rejection and this will probably
be treatable with a decent outcome 3. Recurrent disease and the kidney is not
going to work4. Acute rejection and the kidney is not
going to recover
Connie Frank Transplant Center
This image cannot currently be displayed.
Normal Kidney Biopsy
9/30/2016
5
TOO MUCH BLUE!!!
Connie Frank Transplant Center
Patchy Inflammation
Patcy Infiltrate
Tubulitis???
Severe Interstitial Infiltrate with Lymphocytes Invading the tubules
9/30/2016
6
Fibrinoid Necrosis
Connie Frank Transplant Center
Interstitial Hemorrhage
Connie Frank Transplant Center
9/30/2016
7
Acute T cell-mediated Rejection, Type 3
Fibrinoid necrosis
Connie Frank Transplant Center
Basic Premise: If someone has an acute rejection episode ….. Something needs to change.
• The medications were not working • The patient was under
immunosuppressed• The patient was not taking the
medications as prescribed • Something stimulated the immune
system
Connie Frank Transplant Center
Treatment of Acute Rejection• Depends on:• Timing post-transplant• Severity of rejection • Previous rejection episodes• Comorbid illnesses
Connie Frank Transplant Center
Acute Cellular Rejections: Treatment
• Increase immunosuppression – Thymoglobulin – Steroids– Increase the maintenance
immunosuppression • Early acute rejection has less impact on
long term graft function than late acute rejections
9/30/2016
8
Connie Frank Transplant Center
Graft survival in patients with and without
early acute renal
rejection
El Ters, AJT 2013 Connie Frank Transplant Center
Patie
nts w
ith no
late
rejec
tion (
%)
Primary vs repeat episodes of lateacute rejection
70
75
80
85
90
95
100
0 1 2 3 4 5 6 7 8 9 10
Primary
Repeat
Time post-transplant (years)
Patie
nts c
ontin
ued
on M
MF o
r AZA
Meier-Kriesche H-U et al. Am J Transplant 2002; 2 (Suppl 3):148. Abstract 43.
Connie Frank Transplant Center
Acute Rejections after the 1st yr
• May be triggered by an infection – Viral – Bacterial
• Inadequate immunosuppression– Patient non-adherence – Under immunosuppressed
• Potentially impacts long term outcome of renal function
Connie Frank Transplant Center
<0.00011.74-2.261.98Donor age 60-69<0.00011.82-2.051.93AA recipient
<0.00011.57-1.751.66Previous acute rejection
0.010.83-0.980.90CMV neg→neg<0.00010.88-0.910.90Tx year (per yr)<0.00010.66-0.800.72Living donor<0.00010.27-0.450.35MMFp value95% CIRRVariable
Late acute rejection after 12 monthsCox regression of selected protective & risk factors
Meier-Kriesche H-U et al. Am J Transplant 2002; 2 (Suppl3):148. Abstract 43.
9/30/2016
9
Connie Frank Transplant Center
Chronic Cellular Rejection• Often insidious • Presents with creatinine creep • Treatment – depends on the biopsy
findings – Oral or IV pulse of steroids – Switch to a mTORi from calcineurin
inhibitor
Connie Frank Transplant Center
Relative risk for chronic allograft failure by Cox Proportional Hazard
0
1
2
3
4
5
6
96-97 94-95 92-93 90-91 88-89
1.53 1.37 1.311.14 1
5.2 4.98
3.4
2.351.67
Relat
ive ris
k
Year
No acute rejection
Acuterejection
Meier-Kriesche H-U et al. Transplantation 2000; 70:375-379.
Connie Frank Transplant Center
CHRONIC TRANSPLANT NEPHROPATHY-PATHOGENESIS
• Drug toxicity• Repeated acute rejection (clinical and/or
subclinical)• Loss of renal mass (e.g. size mismatch)• Recurrent or de novo glomerular disease• Combination of all or some of these factors
Connie Frank Transplant Center
CHRONIC TRANSPLANT NEPHROPATHY-PATHOLOGY
• Tubular atrophy• Interstitial fibrosis• Intimal thickening• Glomerulosclerosis
9/30/2016
10
Interstital Fibrosis
Obsolescent Glomeruli
Intimal Thickening
Tubular Atrophy
Dilated Tubules
9/30/2016
11
Connie Frank Transplant Center Connie Frank Transplant Center
Treatment Depends on
– How much scarring is noted on the biopsy – Intensity of Rejection – Type of Rejection – How much immunosuppression the
patient has already seen– Often no more than minor adjustments in
immunosuppression
Connie Frank Transplant Center
Question #3• A 56 yo woman with ESRD due to lupus
received a LRRT from her son 6 years ago. She was known to donor specific antibodies to her son but was desensitized prior to transplant. She has been followed every 6 months and recently noted to have an increase in her proteinuria (UPC 4.6) over the past 6 months. Her creatinine has crept up from 1.5 mg/dl to 2.0 mg/dl over the past 3 months.
Connie Frank Transplant Center
Question #3 You evaluate with an ultrasound which is unremarkable, lupus serologies are negative. Her donor specific antibodies are rechecked and she has developed an increase in the number and intensity of antibodies against her kidney. You discuss performing a biopsy and she asks about what you expect will be the outcome
9/30/2016
12
Connie Frank Transplant Center
Question #3You advise her that based on what you are seeing…1. She has developed diabetes that explains the protein
in her urine 2. Not to worry about it, her kidney function is still
pretty decent, a lot of people spill protein in the urine 3. She likely has developed transplant glomerulopathy
related to injury from the antibodies directed towards the kidney from her son.
4. You have no idea and need to call a transplant Nephrologist immediately
Connie Frank Transplant Center
Question #3You advise her that based on what you are seeing…1. She has developed diabetes that explains the protein
in her urine 2. Not to worry about it, her kidney function is still
pretty decent, a lot of people spill protein in the urine 3. She likely has developed transplant glomerulopathy
related to injury from the antibodies directed towards the kidney from her son.
4. You have no idea and need to call a transplant Nephrologist immediately
Connie Frank Transplant Center
Early Acute Antibody Mediated Rejections
• Highest risk in those with known donor specific antibodies (DSA)
• Patients with high levels of antibodies to human leukocyte antigens (HLA) –high panel reactive antibodies
• Prior transplants • Underlying autoimmune diseases (eg
Lupus)Connie Frank Transplant Center
ACUTE HUMORAL REJECTION PATHOLOGY
• Neutrophils in glomerular and peritubular capillaries
• Fibrin thrombi• May see only edema by LM• C4d by IF staining peritubular capillaries
9/30/2016
13
Connie Frank Transplant Center
Acute/Active AMR
• Tissue injury (x1)• Microvascular inflammation (g>0 and/or ptc>0)• Intimal or transmural arteritis• Thrombotic microangiopathy• Acute tubular necrosis
• Evidence of Antibody/endothelial interaction (x1)• Linear C4d along tubulo-interstitial space capillaries• At least moderate microvascular inflammation• Increased expression of endothelial injury genes
• DSA+ (HLA or other)
Peritubular capillary staining for C4d
Connie Frank Transplant Center
Treatment of Acute AMR• Depends on
– Biopsy findings– Level of antibody (MFI)– Prior treatment for antibody mediated rejection
• Treatment – Plasmapheresis – remove the antibody – IVIG – Rituximab – to block the B cells – Increase baseline immunosuppression – Sometimes eculizumab to block complement– Bortezomib to block plasma cells
9/30/2016
14
Connie Frank Transplant Center
Reversibility of acute AMR (C4d)
pre-treatment 1 month post-treatment Connie Frank Transplant Center JASN 2002;13:2371-2380
cumulative frequency of continuously TxGP-free patients after the early biopsy (until the index biopsy)
and after the index biopsy (until the late follow-up biopsy) according to the absence or presence of
C4d
Connie Frank Transplant Center
Chronic Active AMR
• Morphologic evidence of chronic injury (x1) • Transplant glomerulopathy• Transplant capillaropathy• New onset fibrous intimal thickening of arteries
• Evidence of Ab/endothelial interaction (x1)• Linear C4d along tubulo-interstital capillaries, or
• At least moderate microvascular inflammation• Increased expression of endothelial injury genes
• DSA+(HLA or other)
Connie Frank Transplant Center
Chronic Rejection • Cell Mediated • Antibody Mediated
This territory is a bit like the wild wild west ………….
9/30/2016
15
Connie Frank Transplant Center
Chronic Antibody Mediated Rejection
• Often presents with proteinuria and possible creatinine creep
• Treatment – depends on the biopsy findings – Rarely do plasmapheresis for chronic AMR– IVIG – Possible Riuximab
9/30/2016
16
Connie Frank Transplant Center
Risks with increased immunosuppression
• Infection – Viral
• BK• CMV
• Malignancy – Post-transplant Lymphoproliferative
disorders – Skin Cancers